Literature DB >> 8126821

Polidocanol sclerotherapy for hydroceles and epididymal cysts.

T Sigurdsson1, J E Johansson, S Jahnson, F Helgesen, S O Andersson.   

Abstract

A total of 87 patients with 63 hydroceles and 29 epididymal cysts underwent injection sclerotherapy with polidocanol on an outpatient basis. In the hydrocele group the cure rate after 1 treatment was 67% and the overall cure rate was 87% after a median followup of 14 months. In the group treated for epididymal cyst the corresponding cure rates were 46% and 64%, respectively, with a median followup of 12 months. A low rate of complications was observed. Of 86 evaluable patients 81 (94%) were satisfied with the procedure and the treatment results. Therefore, we recommend injection sclerotherapy with polidocanol as primary treatment for hydroceles and epididymal cysts in patients older than 40 years.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126821     DOI: 10.1016/s0022-5347(17)35117-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Painless treatment of hydrocele: EMLA cream anaesthesia and fibrin adhesive sclerotherapy.

Authors:  M Cecchi; C A Sepich; G Pagni; C Ippolito; R Minervini; L Fiorentini
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

2.  Sclerotherapy for hydrocele revisited: a prospective randomised study.

Authors:  M S Agrawal; H Yadav; A Upadhyay; R Jaiman; J Singhal; A K Singh
Journal:  Indian J Surg       Date:  2009-03-13       Impact factor: 0.656

3.  Does pleurodesis for pleural effusions give bright ideas about the agents for hydrocele sclerotherapy?

Authors:  U Yilmaz; O Ekmekçioğlu; A Tatlişen; D Demirci
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.266

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.